{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:24:49Z","timestamp":1770747889234,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.yebeh.2020.106947","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T17:57:27Z","timestamp":1582653447000},"page":"106947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: A cross-sectional study"],"prefix":"10.1016","volume":"105","author":[{"given":"Sachin","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3587-0968","authenticated-orcid":false,"given":"Sudhir Chandra","family":"Sarangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogendra Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.106947_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2020.106947_bb0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2020.106947_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/0972-2327.160093","article-title":"Epilepsy in India I: epidemiology and public health","volume":"18","author":"Amudhan","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0020","first-page":"1","volume":"498","year":"1972","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.yebeh.2020.106947_bb0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2018.00350","article-title":"Adverse drug reactions in hospitalized patients: results of the FORWARD (Facilitation of Reporting in Hospital Ward) study","volume":"9","author":"Giardina","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5530\/ijpcs.5.4.5","article-title":"Adverse drug reaction monitoring of antipsychotic drugs and mood stabilizers ina teaching hospital","volume":"5","author":"Munoli","year":"2016","journal-title":"Int J Pharmacol Clin Sci"},{"key":"10.1016\/j.yebeh.2020.106947_bb0035","first-page":"441","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"21","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.106947_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2176\/nmc.ra.2015-0344","article-title":"The new antiepileptic drugs: their neuropharmacology and clinical indications","volume":"56","author":"Hanaya","year":"2016","journal-title":"Neurol Med Chir"},{"key":"10.1016\/j.yebeh.2020.106947_bb0045","doi-asserted-by":"crossref","first-page":"922","DOI":"10.18203\/2319-2003.ijbcp20181636","article-title":"A study of serious adverse drug reactions with antiepileptic drugs: a pharmacovigilance study","volume":"7","author":"Khan","year":"2018","journal-title":"Int J Basic Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3189108","article-title":"Antiepileptic drug non-adherence and its predictors among people with epilepsy","volume":"3","author":"Getnet","year":"2016","journal-title":"Behav Neurol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0055","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4103\/0028-3886.241345","article-title":"Cost analysis study of neuropsychiatric drugs: role of national list of essential","volume":"66","author":"Sarangi","year":"2018","journal-title":"Neurol India"},{"issue":"1","key":"10.1016\/j.yebeh.2020.106947_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/ane.13183","article-title":"Seizure-recurrence risk in persons with epilepsy undergoing antiepileptic drug tapering","volume":"141","author":"Kumar","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2020.106947_bb0065","first-page":"7","article-title":"Cost of epilepsy treatment in a state government hospital: a preliminary study","volume":"6","author":"Dhanaraj","year":"2003","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5214\/ans.0972.7531.2006.130403","article-title":"Profile of pharmacotherapy and pharmacoeconomics of epilepsy treatment at a tertiary care hospital","volume":"13","author":"Sigamani","year":"2006","journal-title":"Ann Neurosci"},{"key":"10.1016\/j.yebeh.2020.106947_bb0075","first-page":"1","article-title":"HLA association with drug-induced adverse reactions","volume":"2","author":"Fan","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.yebeh.2020.106947_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2042098611411127","article-title":"New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?","volume":"2","author":"French","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.yebeh.2020.106947_bb0090","author":"WHO"},{"key":"10.1016\/j.yebeh.2020.106947_bb0095","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamaneurol.2014.808","article-title":"Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action","volume":"71","author":"Margolis","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0100","doi-asserted-by":"crossref","first-page":"616","DOI":"10.5455\/njppp.2016.6.0823013082016","article-title":"The pattern of adverse drug events to antiepileptic drugs: a cross-sectional study at a tertiary care teaching hospital","volume":"6","author":"Gajjar","year":"2016","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.14260\/jemds\/2016\/94","article-title":"Drug safety monitoring in patients attending epilepsy clinic in a tertiary care teaching hospital in rural Bengal","volume":"5","author":"Chakrabarty","year":"2016","journal-title":"J Evol Med Dent Sci"},{"key":"10.1016\/j.yebeh.2020.106947_bb0110","first-page":"21","article-title":"Antiepileptic drug utilization and seizure outcome among paediatric patients in a Malaysian public hospital","volume":"51","author":"Hasan","year":"2010","journal-title":"Singapore Med J"},{"key":"10.1016\/j.yebeh.2020.106947_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2010.08.002","article-title":"Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy","volume":"91","author":"Malerba","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.106947_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eplepsyres.2011.02.012","article-title":"Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population","volume":"95","author":"Landmark","year":"2011","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.yebeh.2020.106947_bb9000","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0972-2327.104338","article-title":"Antiepileptic drugs prescription utilization behavior and direct costs of treatment in a national hospital of India","volume":"15","author":"Haroon","year":"2012","journal-title":"Ann Indian Acad Neurol."},{"key":"10.1016\/j.yebeh.2020.106947_bb0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/bmj.318.7176.106","article-title":"Fortnightly review: drug treatment of epilepsy","volume":"318","author":"Feely","year":"1999","journal-title":"BMJ (Clinical Res Ed)"},{"key":"10.1016\/j.yebeh.2020.106947_bb0130","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1007\/s00415-012-6509-3","article-title":"Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany - a nationwide population-based study in children and adults","volume":"259","author":"Hamer","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0135","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00228-008-0480-z","article-title":"Antiepileptic drug utilization in children from 1997 to 2005\u2013a study from the Netherlands","volume":"64","author":"Van de Vrie-Hoekstra","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7324\/JAPS.2016.60518","article-title":"Study on the adverse drug reactions induced by anti-epileptic drugs in the epileptic patients","volume":"6","author":"Jayalekshmi","year":"2016","journal-title":"J Appl Pharm Sci"},{"issue":"Pt A","key":"10.1016\/j.yebeh.2020.106947_bb0145","article-title":"Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: could they have a neuroendocrine correlation in persons with epilepsy?","volume":"100","author":"Sarangi","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2020.106947_bb0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0971-5916.193296","article-title":"Effect of lamotrigine, levetiracetam & topiramate on neurobehavioural parameters & oxidative stress in comparison with valproate in rats","volume":"144","author":"Sarangi","year":"2016","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.yebeh.2020.106947_bb0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.14260\/jemds\/2016\/94","article-title":"Drug safety monitoring in patients attending epilepsy clinic in a tertiary care teaching hospital in rural Bengal","volume":"5","author":"Chakrabarty","year":"2016","journal-title":"J Evol Med Dent Sci"},{"key":"10.1016\/j.yebeh.2020.106947_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008298","article-title":"A prospective study of adverse drug reactions to antiepileptic drugs in children","volume":"5","author":"Anderson","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2020.106947_bb0165","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","article-title":"Relationship between adverse effects of antiepileptic drugs, number of co-prescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy","volume":"51","author":"Canevini","year":"2010","journal-title":"Epilepsia."},{"issue":"8","key":"10.1016\/j.yebeh.2020.106947_bb0170","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00228-019-02678-1","article-title":"Safety aspects of antiepileptic drugs-a population-based study of adverse effects relative to changes in utilisation","volume":"75","author":"Baftiu","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2020.106947_bb0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpn.2018.01.027","article-title":"How do parents perceive adverse drug events of their children's anticonvulsant medication?","volume":"22","author":"Bach","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0091270011433327","article-title":"An algorithm to detect adverse drug reactions in the neonatal intensive care unit: a new approach","volume":"53","author":"Du","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.seizure.2015.02.025","article-title":"Effect of reduction of antiepileptic drugs in patients with drug-refractory epilepsy","volume":"27","author":"Dash","year":"2015","journal-title":"Seizure."},{"issue":"5","key":"10.1016\/j.yebeh.2020.106947_bb0190","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eplepsyres.2014.01.014","article-title":"Effect of antiepileptic therapy on trace elements status in Indian population in a tertiary care hospital from northern India: a cross sectional study","volume":"108","author":"Sarangi","year":"2014","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.yebeh.2020.106947_bb0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0971-5916.182623","article-title":"Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs","volume":"143","author":"Sarangi","year":"2016","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.yebeh.2020.106947_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNF.0b013e31829a498d","article-title":"Adverse effects of antiepileptic drugs in North Indian pediatric outpatients","volume":"36","author":"Bansal","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2020.106947_bb0205","first-page":"96","article-title":"Drug utilization pattern of antiepileptic drugs: a pharmacoepidemiologic and pharmacovigilance study in a tertiary teaching hospital in India","volume":"4","author":"Pal","year":"2011","journal-title":"Asian J Pharm Clin Res"},{"key":"10.1016\/j.yebeh.2020.106947_bb0210","first-page":"25","article-title":"A study on trends in prescribing pattern of anti-epileptic drugs in tertiary care teaching hospital","volume":"3","author":"Murthy","year":"2012","journal-title":"Int J ChePharmace Sci"},{"key":"10.1016\/j.yebeh.2020.106947_bb0215","first-page":"37","article-title":"Phenytion, carbamazepine, sodium valproate and lamotrigine induced cutaneous reactions","volume":"43","author":"Ghaffarpour","year":"2005","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.yebeh.2020.106947_bb0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2019.07.003","article-title":"Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting","volume":"72","author":"Fowler","year":"2019","journal-title":"Seizure."},{"key":"10.1016\/j.yebeh.2020.106947_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/ane.13218","article-title":"Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate","author":"Rogin","year":"2020","journal-title":"Acta Neurol Scand"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019313812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019313812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:31:15Z","timestamp":1761503475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019313812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":45,"alternative-id":["S1525505019313812"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.106947","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.106947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106947"}}